Cas no 28252-80-4 (4,8-Dichloro-1,5-naphthyridine)
4,8-Dichloro-1,5-naphthyridine Chemical and Physical Properties
Names and Identifiers
-
- 4,8-Dichloro-1,5-naphthyridine
- 1,5-Naphthyridine, 4,8-dichloro-
- 4,8-Dichlor1,5-naphthyridin
- 4,8-Dichlor-1,5-naphthyridin
- 4,8-dichloro-[1,5]naphthyridine
- 4,8-Dichloro[1,5]naphthyridine
- AC1LCW3E
- AK127046
- CTK8H9939
- KB-239723
- SureCN7014902
- SCHEMBL7014902
- F21114
- DB-090516
- SQLGCTFYLAMNAC-UHFFFAOYSA-N
- 28252-80-4
- 4,8-Dichloro[1,5]naphthyridine #
- SY365475
- DTXSID50345877
- MFCD26743450
-
- MDL: MFCD26743450
- Inchi: 1S/C8H4Cl2N2/c9-5-1-3-11-8-6(10)2-4-12-7(5)8/h1-4H
- InChI Key: SQLGCTFYLAMNAC-UHFFFAOYSA-N
- SMILES: ClC1C=CN=C2C(=CC=NC2=1)Cl
Computed Properties
- Exact Mass: 197.97532
- Monoisotopic Mass: 197.9751535g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 0
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.5
- Topological Polar Surface Area: 25.8?2
Experimental Properties
- Density: 1.486±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 274-276 oC
- Solubility: Almost insoluble (0.086 g/l) (25 o C),
- PSA: 25.78
4,8-Dichloro-1,5-naphthyridine Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Storage Condition:Inert atmosphere,2-8°C(BD248837)
4,8-Dichloro-1,5-naphthyridine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A219007831-1g |
4,8-Dichloro-1,5-naphthyridine |
28252-80-4 | 95% | 1g |
$970.20 | 2023-09-02 | |
| Chemenu | CM140654-1g |
4,8-dichloro-1,5-naphthyridine |
28252-80-4 | 95% | 1g |
$916 | 2021-08-05 | |
| Chemenu | CM140654-1g |
4,8-dichloro-1,5-naphthyridine |
28252-80-4 | 95% | 1g |
$*** | 2023-03-30 |
4,8-Dichloro-1,5-naphthyridine Related Literature
-
1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
Additional information on 4,8-Dichloro-1,5-naphthyridine
Introduction to 4,8-Dichloro-1,5-naphthyridine (CAS No. 28252-80-4)
4,8-Dichloro-1,5-naphthyridine, identified by the Chemical Abstracts Service Number (CAS No.) 28252-80-4, is a significant heterocyclic compound that has garnered considerable attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the naphthyridine class, a nitrogen-containing heterocycle that exhibits a broad spectrum of biological activities. The presence of chlorine substituents at the 4th and 8th positions enhances its reactivity and functionalization potential, making it a valuable intermediate in the synthesis of various pharmacologically active molecules.
The structural framework of 4,8-Dichloro-1,5-naphthyridine consists of two fused pyridine rings, with electron-withdrawing chlorine atoms positioned at the 4- and 8-positions. This particular arrangement imparts unique electronic and steric properties to the molecule, which are exploited in its application as a building block for more complex drug candidates. The compound’s ability to undergo selective functionalization at the chlorine sites allows for the introduction of diverse pharmacophores, facilitating the development of novel therapeutic agents.
In recent years, 4,8-Dichloro-1,5-naphthyridine has been extensively studied for its potential in drug discovery, particularly in the design of small-molecule inhibitors targeting various biological pathways. One of the most notable areas of research involves its application in anticancer therapy. Studies have demonstrated that derivatives of this compound can interact with key enzymes involved in tumor proliferation and survival. For instance, modifications at the chlorine positions have been shown to enhance binding affinity to proteins such as kinases and transcription factors, which are critical in cancer cell signaling pathways.
Moreover, the pharmaceutical industry has leveraged 4,8-Dichloro-1,5-naphthyridine as a precursor in the synthesis of compounds with antimicrobial properties. Emerging research indicates that certain derivatives exhibit potent activity against resistant bacterial strains by inhibiting essential bacterial enzymes. This finding is particularly relevant in light of the growing global concern over antibiotic resistance. The chlorine substituents in 4,8-Dichloro-1,5-naphthyridine play a pivotal role in modulating the compound’s interactions with bacterial targets, thereby enhancing its efficacy.
Another exciting application of 4,8-Dichloro-1,5-naphthyridine lies in its role as a scaffold for developing neuroprotective agents. Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are major public health challenges, and there is an urgent need for innovative therapeutic strategies. Preliminary studies suggest that derivatives of this compound can cross the blood-brain barrier and exert protective effects on neuronal cells by modulating oxidative stress and inflammation pathways. The versatility of 4,8-Dichloro-1,5-naphthyridine in serving as a chemical scaffold for such applications underscores its importance in modern medicinal chemistry.
The synthetic utility of 4,8-Dichloro-1,5-naphthyridine is another area where it has made significant contributions. Its chlorine substituents provide reactive sites for nucleophilic substitution reactions, enabling chemists to introduce various functional groups with high precision. This flexibility has been exploited in multi-step synthetic routes leading to complex drug molecules. For example, palladium-catalyzed cross-coupling reactions have been employed to incorporate aryl or vinyl groups at specific positions on the naphthyridine core. Such modifications have led to the discovery of novel compounds with enhanced pharmacological profiles.
In conclusion,4,8-Dichloro-1,5-naphthyridine (CAS No. 28252-80-4) is a versatile and highly valuable compound in pharmaceutical research and drug development. Its unique structural features and reactivity make it an indispensable tool for synthesizing molecules with diverse biological activities. As ongoing research continues to uncover new applications for this compound and its derivatives,4,8-Dichloro-1,5-naphthyridine is poised to remain at the forefront of medicinal chemistry innovation.
28252-80-4 (4,8-Dichloro-1,5-naphthyridine) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)